Solubility and dissolution studies of tibolone polymorphs

Different solid forms of an active pharmaceutical ingredient can have distinct chemical and physical characteristics. In this work, we studied the solubility and dissolution properties of the described tibolone polymorphic forms (I and II). Both forms were successively recrystallized and characteriz...

Descripción completa

Detalles Bibliográficos
Autores: Bonfilio, Rudy, Souza, Marília Cristina Oliveira, Leal, Jockastta Silva, Viana, Olímpia Maria Martins Santos, Doriguetto, Antônio Carlos, Araújo, Magali Benjamin de
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2017
País:Brasil
Institución:Universidade de São Paulo (USP)
Repositorio:Brazilian Journal of Pharmaceutical Sciences
Idioma:inglés
OAI Identifier:oai:revistas.usp.br:article/144061
Acceso en línea:https://www.revistas.usp.br/bjps/article/view/144061
Access Level:acceso abierto
Palabra clave:Tibolone/polymorphs
Powder X-ray diffraction/methods
Infrared spectroscopy/methods
Solubility/drug effects
Dissolution/analysis
Descripción
Sumario:Different solid forms of an active pharmaceutical ingredient can have distinct chemical and physical characteristics. In this work, we studied the solubility and dissolution properties of the described tibolone polymorphic forms (I and II). Both forms were successively recrystallized and characterized by powder X-ray diffraction and attenuated total reflection infrared spectroscopy. Equilibrium solubility and dissolution profiles were performed for both forms. Solubility studies demonstrated that form II is statistically more soluble in water, 0.01 mol L-1 HCl and pH 4.5 acetate buffer. The solubility of forms I and II were explained in terms of crystal packing. Dissolution tests of tablets showed a lower release of polymorphic form II than form I from tablets. The results showed an impact of polymorphism on the quality of tibolone tablets and suggest that tibolone forms I and II can show distinct interactions with pharmaceutical excipients used in tablets. Therefore, only form I is acceptable for the preparation of tablet forms. Based on our results, we propose the quality control on tibolone raw materials using X-ray diffraction analysis and attenuated total reflection infrared spectroscopy.